DK172587B1 - Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde - Google Patents

Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde Download PDF

Info

Publication number
DK172587B1
DK172587B1 DK198801830A DK183088A DK172587B1 DK 172587 B1 DK172587 B1 DK 172587B1 DK 198801830 A DK198801830 A DK 198801830A DK 183088 A DK183088 A DK 183088A DK 172587 B1 DK172587 B1 DK 172587B1
Authority
DK
Denmark
Prior art keywords
analyte
receptor
binding sites
labeled
marker
Prior art date
Application number
DK198801830A
Other languages
Danish (da)
English (en)
Other versions
DK183088D0 (da
DK183088A (da
Inventor
Roger Philip Ekins
Original Assignee
Multilyte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868619206A external-priority patent/GB8619206D0/en
Application filed by Multilyte Ltd filed Critical Multilyte Ltd
Publication of DK183088D0 publication Critical patent/DK183088D0/da
Publication of DK183088A publication Critical patent/DK183088A/da
Application granted granted Critical
Publication of DK172587B1 publication Critical patent/DK172587B1/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DK198801830A 1986-08-06 1988-04-05 Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde DK172587B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB868619206A GB8619206D0 (en) 1986-08-06 1986-08-06 Fluorometric determination of analyte concentration
GB8619206 1986-08-06
PCT/GB1987/000558 WO1988001058A1 (fr) 1986-08-06 1987-08-06 Determination de la concentration d'analyte a l'aide de deux substances de marquage
EP87306995A EP0271974B1 (fr) 1986-08-06 1987-08-06 Détermination de la concentration d'analyte utilisant deux étiquettes
GB8700558 1987-08-06
EP87306995 1987-08-06

Publications (3)

Publication Number Publication Date
DK183088D0 DK183088D0 (da) 1988-04-05
DK183088A DK183088A (da) 1988-04-05
DK172587B1 true DK172587B1 (da) 1999-02-08

Family

ID=26110703

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801830A DK172587B1 (da) 1986-08-06 1988-04-05 Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde

Country Status (8)

Country Link
US (3) US5171695A (fr)
JP (1) JP2690011B2 (fr)
AT (1) ATE86385T1 (fr)
AU (1) AU614935B2 (fr)
DK (1) DK172587B1 (fr)
FI (1) FI92881C (fr)
NO (1) NO172517C (fr)
WO (1) WO1988001058A1 (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599720A (en) * 1982-08-27 1997-02-04 Multilyte Limited Measurement of analyte concentration
US5807755A (en) * 1987-08-06 1998-09-15 Multilyte Limited Determination of ambient concentrations of several analytes
GB8803000D0 (en) * 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6379895B1 (en) 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
CA2021658C (fr) * 1989-08-25 2001-10-09 Myron J. Block Systeme multiplex de dosage immunologique
US6008057A (en) * 1989-08-25 1999-12-28 Roche Diagnostics Corporation Immunoassay system
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
EP0515370B1 (fr) * 1990-02-22 1995-03-01 THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING (McGILL UNIVERSITY) Systeme d'immunoanalyse interferometrique a phase solide
EP0608370B1 (fr) * 1991-10-15 1998-01-07 Multilyte Limited Methode de dosage par liaison a l'aide d'un reactif marque
US6943034B1 (en) 1991-11-22 2005-09-13 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
US5960344A (en) * 1993-12-20 1999-09-28 Norand Corporation Local area network having multiple channel wireless access
GB9326451D0 (en) * 1993-12-24 1994-02-23 Multilyte Ltd Binding assay
GB9326450D0 (en) * 1993-12-24 1994-02-23 Multilyte Ltd Binding assay
US7625697B2 (en) 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US5751629A (en) 1995-04-25 1998-05-12 Irori Remotely programmable matrices with memories
US5874214A (en) 1995-04-25 1999-02-23 Irori Remotely programmable matrices with memories
US6329139B1 (en) 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US6331273B1 (en) 1995-04-25 2001-12-18 Discovery Partners International Remotely programmable matrices with memories
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US6416714B1 (en) 1995-04-25 2002-07-09 Discovery Partners International, Inc. Remotely programmable matrices with memories
US5679309A (en) * 1995-12-14 1997-10-21 Beckman Instruments, Inc. Automated random access analyzer
US6709869B2 (en) 1995-12-18 2004-03-23 Tecan Trading Ag Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system
US5874216A (en) * 1996-02-23 1999-02-23 Ensys Environmental Products, Inc. Indirect label assay device for detecting small molecules and method of use thereof
EP0904542B1 (fr) * 1996-03-01 2005-06-29 Beckman Coulter, Inc. Systeme d'essais multiples simultanes de fixation de ligands
EP0795752B1 (fr) * 1996-03-13 2001-10-10 F.Hoffmann-La Roche Ag Procédé et dispositif optochimique pour déterminer la concentration d'un analyte
US6143248A (en) * 1996-08-12 2000-11-07 Gamera Bioscience Corp. Capillary microvalve
AU5895898A (en) 1996-12-20 1998-07-17 Gamera Bioscience Corporation An affinity binding-based system for detecting particulates in a fluid
US6632399B1 (en) * 1998-05-22 2003-10-14 Tecan Trading Ag Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system for performing biological fluid assays
WO1998053311A2 (fr) 1997-05-23 1998-11-26 Gamera Bioscience Corporation Dispositifs et procedes permettant d'utiliser l'acceleration centripete pour commander le deplacement de fluides sur un systeme microfluidique
WO1999009394A1 (fr) 1997-08-15 1999-02-25 Alexion Pharmaceuticals, Inc. Dispositif permettant de realiser des dosages au niveau de sites reactionnels
US7157234B2 (en) 1997-10-24 2007-01-02 Beckman Coulter, Inc. Detection of very low quantities of analyte bound to a solid phase
GB9808836D0 (en) 1998-04-27 1998-06-24 Amersham Pharm Biotech Uk Ltd Microfabricated apparatus for cell based assays
GB9809943D0 (en) * 1998-05-08 1998-07-08 Amersham Pharm Biotech Ab Microfluidic device
AU5494900A (en) * 1999-06-18 2001-01-09 Gamera Bioscience Corporation Devices and methods for the performance of miniaturized homogeneous assays
US6645733B1 (en) * 1999-06-25 2003-11-11 Ingeneus Corporation Fluorescent intensity method for assaying binding between proteins or peptides
US6267884B1 (en) * 2000-01-04 2001-07-31 Waters Investments Limited Capillary columns employing monodispersed particles
AU2001292959A1 (en) 2000-09-22 2002-04-02 Clontech Laboratories, Inc. Highly sensitive proteomic analysis methods and kits and systems for practicing the same
WO2002038812A2 (fr) * 2000-11-07 2002-05-16 Denton Richard V Nouveau procede en matiere d'analyse quantitative de l'expression de genes et de proteines
JP3856214B2 (ja) * 2002-03-11 2006-12-13 横河電機株式会社 蛍光強度増強ビーズ
US20050079507A1 (en) * 2003-10-09 2005-04-14 Ye Fang Target evaluation using biological membrane arrays
GB0421838D0 (en) 2004-09-30 2004-11-03 Congenia S R L Cancer markers
US20060263265A1 (en) * 2005-05-23 2006-11-23 Der-Ren Kang Blood micro-separator
US20070111326A1 (en) * 2005-11-14 2007-05-17 Abbott Laboratories Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
AU2007273055B2 (en) 2006-07-14 2014-05-01 The Regents Of The University Of California Cancer biomarkers and methods of use thereof
EP3508854A1 (fr) 2010-04-27 2019-07-10 The Regents of The University of California Biomarqueurs du cancer et leurs procédés d'utilisation
GB201016403D0 (en) 2010-09-29 2010-11-10 Bath Ventures Novel interaction between staphylococcus aureus Sbi and C3d protiens
EP3227687A4 (fr) 2014-12-05 2018-10-24 Prelude, Inc. Récurrence de carcinome canalaire in situ (dcis) et cancer du sein invasif
JP7141405B2 (ja) * 2017-02-09 2022-09-22 プロメガ コーポレイション 検体検出イムノアッセイ
AU2019339508A1 (en) 2018-09-14 2021-04-15 Prelude Corporation Method of selection for treatment of subjects at risk of invasive breast cancer
GB2602268B (en) * 2020-12-18 2022-12-14 Forsite Diagnostics Ltd Time-resolved fluorescence reader and method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341957A (en) * 1975-11-26 1982-07-27 Analytical Radiation Corporation Fluorescent antibody composition for immunofluorometric assay
CA1111762A (fr) * 1977-12-28 1981-11-03 David S. Frank Chelate de terre rare fluorescent dans des particules de latex polymerique
US4381291A (en) * 1979-02-23 1983-04-26 Ab Fortia Measurement of free ligands
GB2057685B (en) * 1979-03-19 1983-12-21 Int Diagnostic Tech Double tagged immunoassay
JPS5651665A (en) * 1979-09-24 1981-05-09 Radiochemical Centre Ltd Method of analysing isolated part of matter in biological fluid
US4366143A (en) * 1979-09-24 1982-12-28 Amersham International Public Limited Company Assay for the free portion of substances in biological fluids
JPH0664059B2 (ja) * 1982-08-27 1994-08-22 マルティライト リミティド 被検体の濃度の測定方法

Also Published As

Publication number Publication date
US20030082832A1 (en) 2003-05-01
WO1988001058A1 (fr) 1988-02-11
ATE86385T1 (de) 1993-03-15
AU7755987A (en) 1988-02-24
NO172517C (no) 1993-07-28
DK183088D0 (da) 1988-04-05
NO881241L (no) 1988-03-21
FI92881C (fi) 1995-01-10
FI92881B (fi) 1994-09-30
US20020160524A1 (en) 2002-10-31
DK183088A (da) 1988-04-05
JPH01503405A (ja) 1989-11-16
FI890526A0 (fi) 1989-02-03
FI890526A (fi) 1989-02-03
AU614935B2 (en) 1991-09-19
NO881241D0 (no) 1988-03-21
JP2690011B2 (ja) 1997-12-10
NO172517B (no) 1993-04-19
US5171695A (en) 1992-12-15

Similar Documents

Publication Publication Date Title
DK172587B1 (da) Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde
CA1113841A (fr) Dispositif de depistage et methode d'utilisation
CN1759319B (zh) 生物液中肾上腺髓质素原中间区域部分肽在制备免疫诊断剂中的用途
FI92110C (fi) Useiden analyyttien vallitsevien konsentraatioiden määrittäminen
JP4619372B2 (ja) 改良された対照区画を有する免疫学的試験素子
DK156925B (da) Analytisk multilagsmateriale, dets fremstilling og anvendelse
EP0070300A1 (fr) Systeme en phase solide pour essai avec agent de liaison.
DK172582B1 (da) Fremgangsmåde og testkit til bestemmelse af koncentrationen af en i en biologisk væske tilstedeværende aktiv forbindelse
EP0141298A1 (fr) Méthode et élément analytique pour l'albumine
JPH0750114B2 (ja) 免疫分析器具を用いる分析方法
US4916080A (en) Immunoassay with antigen or antibody labelled microcapsules containing fluorescent substance
US20180074074A1 (en) Homogenous and heterogeneous assays and systems for determination of ocular biomarkers
US4786606A (en) Solid phase system for ligand assay
Gutierrez et al. Immunoassay methods based on fluorescence polarization
US20040161857A1 (en) Test strip for chromatography and process for producing the same
EP0271974B1 (fr) Détermination de la concentration d'analyte utilisant deux étiquettes
US4032626A (en) Reagent and method for tbg assay
WO2005078446A1 (fr) Procede de test rapide
EP0596074A1 (fr) Technique amelioree de lavage pour immunodosage
JPH08297123A (ja) 蛋白質の免疫学的測定法とその方法の実施のためのキット
Arakawa et al. Fluorescent enzyme immunoassay of free thyroxin using glucose oxidase as enzyme label
JP2521074B2 (ja) 免疫反応の調節法
Keller et al. in [nsect tsio [ogy
JPH01257262A (ja) 均質なt−4取込み分析法
Simple et al. PROCEEDINGS OF CSCC CONVENTION

Legal Events

Date Code Title Description
PUP Patent expired